Sodium channels as molecular targets for antiepileptic drugs

Brain Research Reviews

Volumn 26, Issue 1, 1998, Pages 16-28

  Ragsdale, David S ^a,b   Avoli, Massimo ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Antiepileptic drug; Carbamazepine; Lamotrigine; Phenytoin; Sodium channel; Topiramate; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; SODIUM CHANNEL; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; DRUG MECHANISM; EPILEPSY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICONVULSANTS; HUMANS; SODIUM CHANNELS;

EID: 0031966045     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00054-4     Document Type: Review

References (114)

1. + channel. Neuron. 16:1996;1169-1177.
2. Armstrong C.M., Bezanilla F. Currents related to movement of the gating particles of the sodium channels. Nature. 242:1973;459-461.
3. Armstrong C.M., Bezanilla F., Rojas E. Destruction of sodium conductance inactivation in squid axons perfused with pronase. J. Gen. Physiol. 62:1973;375-391.
4. Armstrong C.M., Bezanilla F. Charge movement associated with the opening and closing of the activation gates of the Na channels. J. Gen. Physiol. 63:1974;533-552.
5. + channel α subunit with novel gating properties. Neuron. 1:1988;449-461.
6. Baxter M.G., Miller A.A., Webster R.A. Some studies on the convulsant action of folic acid. Br. J. Pharmacol. 48:1973;350P-351P.
7. Beckh S., Noda M., Lübbert H., Numa S. Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J. 8:1989;3611-3616.
8. Bennett P.B., Valenzuela C., Chen L.-Q., Kallen R.G. On the molecular nature of the lidocaine receptor of cardiac Na channels: modification of block by alterations in the α subunit III-IV interdomain. Circ. Res. 77:1995;584-592.
9. Biton V., Reife R., Kamin M., Bobrosky K. Topiramate (Topamax) as add-on therapy for patients with primary generalized epilepsy. Neurology. 46:1996;A176.
10. Black J.A., Yokoyama S., Higashida H., Ransom B.R., Waxman S.G. Sodium channel mRNAs I, II, III in the CNS: cell-specific expression. Mol. Brain Res. 22:1994;275-289.
11. Brysch W., Creutzfeldt O.D., Lüno, Schlingensiepen R., Schlingensiepen K.-H. Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development. Exp. Brain Res. 86:1991;562-567.
12. Brown S.D., Wolf H.H., Swinyard W.A., Twyman R.E. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia. 34:1993;122-123. Suppl. 2.
13. Burgess D.L., Kohrman D.C., Galt J., Plummer N.W., Jones J.M., Spear B., Meisler M.H. Mutation of a new sodium channel gene, Scn8A, in the mouse mutant 'motor endplate disease'. Nat. Genet. 10:1995;461-465.
14. M.D. Cahalan, B.I. Shapiro, W. Almers, Relationship between inactivation of sodium channels and block by quaternary derivatives of local anesthetics and other compounds, in: B.R. Fink (Ed.), Molecular Mechanisms of Anesthesia (Progress in Anesthesiology), Vol. 2, Raven Press, New York, 1980, pp. 17-33.
15. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol. Sci. 8:1987;7-65.
16. + channels. Physiol. Rev. 72:1992;S15-S48.
17. + current of mammalian CNS neurons. NeuroReport. 6:1995;1778-1780.
18. Cheung H., Kamp D., Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13:1992;107-112.
19. Coulter D.A., Sombati S., Delorenzo R.J. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia. 34:1993;123.
20. Coulter D.A., Sombati S., Delorenzo R.J. Topiramate effects on excitatory amino acid mediated responses in cultured hippocampal neurons: selective blockade of kainate currents. Epilepsia. 36:1995;40.
21. + current in mammalian central neurons. Annu. Rev. Physiol. 58:1996;349-362.
22. Edmonds H.L. Jr., Jiang Y.D., Zhang P.Y., Shank R.P. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci. 59:1996;PL127-131.
23. Felts P.A., Yoloyama S., Dibhajj S., Black J.A., Waxman S.G. Sodium channel α subunit mRNAs I, II, III, NaG, Na6 and HNE (PN1) - Different expression patterns in developing rat nervous system. Mol. Brain Res. 45:1997;71-82.
24. Filatov G.N., Kraner S.D., Barchi R.L. Secondary structure of the D4/S4-5 linker probed by systematic cysteine accessibility method. Biophys. J. 72:1997;A260.
25. Fozzard H.A., Hank D.A. Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol. Rev. 76:1996;887-926.
26. Gingrich K.J., Beardsley D., Yue D.T. Ultra-deep blockage of Na channels by a quaternary ammonium ion: catalysis by a transition-intermediate state. J. Physiol. 471:1993;319-341.
27. II sodium channel subtypes. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8682-8686.
28. Gustafson T.A., Clevinger E.C., O'Neill T.J., Yarowsky P.J., Krueger B.K. Mutually exclusive exon splicing of type III brain sodium channel α subunit RNA generates developmentally regulated isoforms in rat brain. J. Biol. Chem. 268:1993;18648-18653.
29. Guy H.R., Seetharamulu P. Molecular model of the action potential sodium channel. Proc. Natl. Acad. Sci. U.S.A. 83:1986;508-512.
30. Heinemann S.H., Terlau H., Stümer W., Imoto K., Numa S. Calcium channel characteristics conferred on the sodium channel by single mutations. Nature. 356:1992;441-443.
31. Hill B. Local anesthetics: hydrophobic and hydrophillic pathways for the drug-receptor reaction. J. Gen. Physiol. 69:1977;497-515.
32. B. Hille, Ionic Channels of Excitable Membranes, Sinauer Assoc., Sunderland, MA, 1992.
33. Hodgkin A.L., Huxley A.F. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J. Physiol. (London). 116:1952;449-472.
34. Hodgkin A.L., Huxley A.F. The components of membrane conductance in the giant axon of Loligo. J. Physiol. (London). 116:1952;473-496.
35. Hodgkin A.L., Huxley A.F. The dual effect of membrane potential on sodium conductance in the giant axon of Loligo. J. Physiol. (London). 116:1952;497-506.
36. Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (London). 117:1952;500-544.
37. Hondeghem L.M., Katzung B.G. Time- and voltage-dependent interaction of antiarrhythmic drugs with cardiac sodium channels. Biochim. Biophys. Acta. 472:1977;373-398.
38. Isom L.L., DeJongh K.S., Patton D.E., Reber B.F.X., Offord J., Charbonneau H., Scheuer T., Catterall W.A. Primary structure and functional expression of the β1 subunit of the rat brain sodium channel. Science. 256:1992;839-842.
39. Isom L.L., DeJongh K.S., Catterall W.A. Auxiliary subunits of voltage-gated ion channels. Neuron. 12:1994;1183-1194.
40. Isom L.L., Ragsdale D.S., DeJongh K.S., Westenbroek R., Reber B.F.X., Scheuer T., Catterall W.A. Structure and function of the β2 subunit of sodium channels, a transmembrane glycoprotein with a CAM motif. Cell. 83:1995;433-442.
41. Isom L.L., Scheuer T., Brownstein A.B., Ragsdale D.S., Murphy B.J., Catterall W.A. Functional co-expression of the β1 and type IIA α subunits of sodium channels in a mammalian cell line. J. Biol. Chem. 270:1995;3306-3312.
42. + channel subunits and Ig domains. Nature. 383:1996;307-308.
43. Joho R.J., Moorman J.R., VanDongen A.M.J., Kirsch G.E., Silberberg H., Schuster G., Brown A.M. Toxin and kinetic profile of rat brain type III sodium channels expressed in Xenopus oocytes. Mol. Brain Res. 7:1990;105-113.
44. Kallen R.G., Cohen S.A., Barchi R.L. Structure, function and expression of voltage-dependent sodium channels. Mol. Neurobiol. 7:1993;383-428.
45. Kayano T., Noda M., Flockerzi H., Takahashi H., Numa S. Primary structure of rat brain sodium channel III deduced from the cDNA sequence. FEBS Lett. 228:1988;187-194.
46. Khodorov B.I. Role of inactivation in local anesthetic action. Ann. NY Acad. Sci. 625:1991;225-248.
47. Krafte D.S., Goldin A.L., Auld V.J., Dunn R.J., Davidson N., Lester H.A. Inactivation of cloned sodium channels expressed in Xenopus oocytes. J. Gen. Physiol. 96:1990;689-706.
48. Kuo C.C., Bean B.P. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol. Pharmacol. 46:1994;716-725.
49. + channels must deactivate to recover from inactivation. Neuron. 12:1994;819-829.
50. + currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol. Pharmacol. 51:1997;1077-1083.
51. Lang D.G., Wang C.M., Barrett R.C. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 266:1993;829-834.
52. Larsson H.P., Baker O.S., Dhillon S.S., Isacoff E.Y. Transmembrane movement of the Shaker K channel S4. Neuron. 16:1996;387-397.
53. Lees G., Leach M.J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 612:1993;190-199.
54. Litt M., Luty J., Kwak M., Allen L., Magenis R.E., Mandel G. Localization of a human brain sodium channel gene (Scn2A) to chromosome 2. Genomics. 5:1989;204-208.
55. MacKinnon R. Pore loops: an emerging theme in ion channel structure. Neuron. 14:1995;889-892.
56. Malo D., Schurr E., Dorfman J., Canfield V., Levenson R., Gros P. Three brain sodium channel α subunit genes are clustered on the proximal segment of mouse chromosome 2. Genomics. 10:1991;666-672.
57. Malo M.S., Blanchard B.J., Andresen J.M., Srivastava K., Chen X.N., Li X., Jabs E.W., Korenberg J.R., Ingram V.M. Localization of a putative human brain sodium channel gene (Scn1A) to chromosome band 2q24. Cytogenet. Cell Genet. 67:1994;178-186.
58. Malo M.S., Srivastava K., Andresen J.M., Chen X.N., Korenberg J.R., Ingram V.M. Targeted gene walking by low stringency polymerase chain reaction: assignment of a putative human brain sodium channel gene (Scn3A) to chromosome 2q24-31. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2975-2979.
59. Marangos P.J., Post R.M., Patel J., Zander K., Parma A., Weiss S. Specific and potent interactions of carbamazepine with brain adenosine receptors. Eur. J. Pharmacol. 93:1983;175-182.
60. Matsuki N.F., Quandt N., Ten Eick R.E., Yeh J.Z. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 228:1984;523-530.
61. McLean M.J., Macdonald R.L. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 227:1983;779-789.
62. McLean M.J., Macdonald R.L. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 238:1986;727-738.
63. McLean M.J., Macdonald R.L. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237:1986;1001-1011.
64. McPhee J.C., Ragsdale D.S., Scheuer T., Catterall W.A. A critical role for transmembrane segment IVS6 of the sodium channel α subunit in fast inactivation. J. Biol. Chem. 270:1995;12025-12034.
65. + channel α subunit in fast inactivation. Biophys. J. 70:1996;A318.
66. Merritt H.H., Putman T.J. A new series of anticonvulsant drugs tested by experiments on animals. Arch. Neurol. Psychiatry. 39:1938;1003-1015.
67. Mitrovic N., Lerche H., Heine R., Fleischauer R., Pika-Hartlaub U., Hartlaub U., George A.L. Jr., Lehmann-Horn F. Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human skeletal muscle Na channel. Neurosci. Lett. 214:1996;9-12.
68. Nakamura J., Tamura S., Kanda T., Ishii A., Ishihara K., Serikawa T., Yamada J., Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur. J. Pharmacol. 254:1994;83-89.
69. Noda M., Shimizu S., Tanabe T., Takai T., Kayano T., Ideda T., Takahashi H., Nakayama H., Kanaoka Y., Minamino N.et al. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature. 312:1984;121-127.
70. Noda M., Ideda M., Kayano T., Suzuki H., Takeshima H., Kurasaki M., Takahashi H., Numa S. Existence of distinct sodium channel messenger RNAs in rat brain. Nature. 320:1986;188-192.
71. Noda M., Ideda T., Suzuki T., Takeshima H., Takahashi T., Kuno M., Numa S. Expression of functional sodium channels from cloned cDNA. Nature. 322:1986;826-828.
72. Numa S. A molecular view of neurotransmitter receptors and ionic channels. Harvey Lect. 83:1989;121-165.
73. Obbens E.A.M.T., Hommes O.R. The epileptogenic effects of folate derivatives in the rat. J. Neurol. Sci. 20:1973;223-229.
74. + channel inactivation: change neutralizations and deletions in the III-IV linker. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10905-10909.
75. Plummer N.W., McBurney M.W., Meisler M.H. Alternative splicing of the sodium channel Scn8A predicts a truncated two-domain protein in fetal brain and non-neuronal cells. J. Biol. Chem. 272:1997;24008-24015.
76. Purdy R.E., Julien R.M., Fairhurst A.S., Terry M.D. Effect of carbamazepine on the in vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes. Epilepsia. 18:1994;251-257.
77. Ragsdale D.S., Scheuer T., Catterall W.A. Frequency and voltage-dependent inhibition of type IIA Na channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic and anticonvulsant drugs. Mol. Pharmacol. 40:1994;756-765.
78. Ragsdale D.S., McPhee J.C., Scheuer T., Catterall W.A. Molecular determinants of state-dependent block of Na channels by local anesthetics. Science. 265:1994;1724-1728.
79. Ragsdale D.S., McPhee J.C., Scheuer T., Catterall W.A. Common molecular determinants of local anesthetic, antiarrhythmic and anticonvulsant block of voltage-gated Na channels. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9270-9275.
80. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental state compounds. Pharmacol. Rev. 42:1996;223-286.
81. Sachdeo R.C., Sachdeo S.K., Walker S.A., Kramer L.D., Nayak R.K., Doose D.R. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia. 37:1996;774-780.
82. Sarao R., Gupta S.K., Auld V.J., Dunn R.J. Developmentally regulated alternative RNA splicing of rat brain Na channel mRNAs. Nucleic Acids Res. 19:1991;5673-5679.
83. Sather W.A., Yang J., Tsien R.W. Structural basis of ion channel permeation and selectivity. Curr. Opin. Neurobiol. 4:1994;313-323.
84. Schaller K.L., Krzemien D.M., Yarowsky P.J., Krueger B.K., Caldwell J.H. Novel, abundant sodium channel expressed in neurons and glia. J. Neurosci. 15:1994;3231-3242.
85. Schneider M.F., Chandler W.K. Voltage-dependent charge movement in skeletal muscle: a possible step in excitation-contraction coupling. Nature. 242:1973;244-246.
86. Schwarz J.R., Grigat G. Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers. Epilepsia. 30:1989;286-294.
87. Segal M.M., Douglas A.F. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J. Neurophysiol. 77:1997;3021-3034.
88. Seoh S.-A., Sigg D., Papazian D.M., Bezanilla F. Voltage-sensing residues in the S2 and S4 segments of the Shaker K channel. Neuron. 16:1996;1159-1167.
89. Shank R.P., Gardocki J.F., Vaught J.L., Davis C.B., Schupsky J.J., Raffa R.B., Dodgson S.J., Nortey S.O., Maryanoff B.E. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 35:1994;450-460.
90. Skerritt J.H., Davies L.P., Johnston G.A.R. Interaction of the anticonvulsant carbamazepine with adenosine receptors: 1. Neurochemical studies. Epilepsia. 24:1983;634-642.
91. Strichartz G.R. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J. Gen. Physiol. 62:1973;37-57.
92. Stümer W., Conti F., Suzuki H., Wang X., Noda M., Yahadi N., Kubo H., Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature. 339:1989;597-603.
93. Tang L., Kallen R.G., Horn R. Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker. J. Gen. Physiol. 108:1996;89-104.
94. Tassinari C.A., Michelucci R., Chauvel P., Chodkiewecz J., Shorvon S., Henriksen O., Dam M., Reife R., Pledger G., Karim R. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia. 37:1996;763-768.
95. C.P. Taylor, L.S. Narasimhan, Sodium channels and therapy of central nervous system diseases, Adv. Pharmacol., 39 (1997) 47-98.
96. Timmings P.L., Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. Eur. Neurol. 32:1992;305-307.
97. Toman J.E.P. The neuropharmacology of antiepileptics. Electroencephalogr. Clin. Neurophysiol. 1:1949;33-44.
98. Ukomadu C., Zhou J., Sigworth F.J., Agnew W.S. μl Na channels expressed transiently in human embryonic kidney cells: biochemical and biophysical properties. Neuron. 8:1992;663-676.
99. Vassilev P.M., Scheuer T., Catterall W.A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science. 241:1988;1658-1661.
100. Vega-Saenz De Miera E., Rudy B., Sugimori M., Llinás R. Molecular characterization of the sodium channel subunits expressed in mammalian cerebellar Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7059-7064.
101. Wakamori M., Kaneda M., Oyama Y., Akaike N. Effects of chlordiazepoxide, chloropromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current of isolated mammalian brain neurons. Brain Res. 494:1989;374-378.
102. Wauquier A., Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. 24:1996;73-77.
103. West J.W., Patton D.E., Scheuer T., Wang Y., Goldin A.L., Catterall W.A. A cluster of hydrophobic amino acid residues required for fast Na channel inactivation. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10910-10914.
104. West J.W., Scheuer T., Maechler L., Catterall W.A. Efficient expression of rat brain type IIA Na channel α subunits in a somatic cell line. Neuron. 8:1992;59-70.
105. + channel subtypes in central neurons. Neuron. 3:1989;695-704.
106. Willow M., Gonoi T., Catterall W.A. Voltage-clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol. 27:1985;549-558.
107. Xie X., Lancaster B., Peakman T., Garthwaite J. Interactions of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na channels and native Na channels in rat hippocampal neurons. Pflüg. Arch. 430:1995;437-446.
108. Yang N., George A.L. Jr., Horn R. Molecular basis of charge movement in voltage-gated sodium channels. Neuron. 16:1996;113-122.
109. Yuen A.W. Lamotrigine: a review of antiepileptic efficacy. Epilepsia. 35:1994;S33-S36.
110. Zamponi G.W., French R.J. Amine blockers of the cytoplasmic mouth of sodium channels: a small structural change can abolish voltage dependence. Biophys. J. 67:1994;1015-1027.
111. Zha H., Remmers E.F., Du Y., Goldmuntz E.A., Mathern P., Zhang H., Cash J.M., Crofford L.J., Wilder R.L. A single linkage group comprising 11 polymorphic DNA markers on rat chromosome 3. Mammal. Genome. 5:1994;538-541.
112. Zona C., Avoli M. Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture. Exp. Brain Res. 81:1990;313-317.
113. Zona C., Ciotti M.T., Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231:1997;123-126.
114. Zona C., Avoli M. Lamotrigine reduces voltage-gated sodium currents in rat central neurons in culture. Epilepsia. 38:1997;522-525.